Issue 1, 2004

Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways

Abstract

The synthesis of C(4)H and C(4)Me analogues of the JNK/p38 pathway activator anisomycin, based upon an aldol or Claisen construction of the C(3)–C(4) bond, has been demonstrated. The relative activation of the JNK/SAPK1 and p38/SAPK2 pathways in RAW macrophages by these analogues, and their synthetic precursors, has been assessed using immunoblot assays against phosphorylated c-Jun and MAPKAP-K2. These studies demonstrate that some of the synthetic C(4) analogues are also potent activators of these stress kinase pathways.

Graphical abstract: Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways

Article information

Article type
Paper
Submitted
15 Sep 2003
Accepted
21 Nov 2003
First published
02 Dec 2003

Org. Biomol. Chem., 2004,2, 142-149

Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways

E. M. Rosser, S. Morton, K. S. Ashton, P. Cohen and A. N. Hulme, Org. Biomol. Chem., 2004, 2, 142 DOI: 10.1039/B311242J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements